ASk Questions in GYnecologic Oncology (ASQ-GYO)

Key facts

Sponsor

Ira Winer

Principal Investigator

Ira Winer, MD PhD, MD

Barbara Ann Karmanos Cancer Institute

Intervention

Administration of the ASk Questions in GYnecologic Oncology (ASQ-GYO) Question Prompt List(behavioral)

Enrollment

70 enrolled

Eligibility

18 years · All sexes

Timeline

2024 – 2028

Study locations (1)

• Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Gestational trophoblastic disease

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE2NCT05635344
  A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia
  Imperial College London
• RECRUITINGNCT02892877
  The French National Reference Centre of GTD
  Hospices Civils de Lyon

See all trials for Gestational trophoblastic disease →